Global Antithrombin Market by Formulation (Liquid, Lyophilized), Source (Goat Milk, Human), Type, Route, Application - Forecast 2024-2030- Product Image

Sale

Global Antithrombin Market by Formulation (Liquid, Lyophilized), Source (Goat Milk, Human), Type, Route, Application - Forecast 2024-2030

Report
180 Pages
March 2024
Region: Global
360iResearch™
ID: 4904661

UP TO €846EUR$875USD£727GBP OFF until Dec 31^st 2024

The Antithrombin Market size was estimated at USD 796.09 million in 2023, USD 876.87 million in 2024, and is expected to grow at a CAGR of 10.24% to reach USD 1,575.32 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Antithrombin Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antithrombin Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Antithrombin Market, highlighting leading vendors and their innovative profiles. These include Bio-Techne Corporation, BioPharm Laboratories, LLC, CSL Limited, Diapharma Group, Inc., European Medicines Agency, Genesis BioPharma, Grifols, S.A., Kedrion S.p.A., Lee Biosolutions, Inc., LFB USA, Inc., Merck KGaA, Octapharma AG, Scripps Laboratories, Inc., Siemens AG, SK Plasma, Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific Inc., and WebMD, LLC.

Market Segmentation & Coverage

This research report categorizes the Antithrombin Market to forecast the revenues and analyze trends in each of the following sub-markets:

Formulation
- Liquid
- Lyophilized
Source
- Goat Milk
- Human
Type
- Anticoagulant
- Antiplatelet
- Thrombolytic Drugs
Route
- Oral
- Parenteral
Application
- Diagnostics
- Research
- Therapeutics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Antithrombin Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antithrombin Market?
What are the technology trends and regulatory frameworks in the Antithrombin Market?
What is the market share of the leading vendors in the Antithrombin Market?
Which modes and strategic moves are suitable for entering the Antithrombin Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Antithrombin Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing occurrence of antithrombin deficiency and increased bleeding during surgeries
5.1.1.2. Utilization of rapid diagnostic tests and need for antithrombin
5.1.1.3. Increasing awareness of the thrombotic disease among consumers
5.1.2. Restraints
5.1.2.1. Capital-intensive production of antithrombin
5.1.3. Opportunities
5.1.3.1. Rising adoption of natural agents in antithrombins
5.1.3.2. Technological advancements in the development of cost-effective procedures in the production of antithrombin
5.1.4. Challenges
5.1.4.1. Limitations of lab testing of antithrombin deficiency
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Antithrombin Market, by Formulation

6.1. Introduction
6.2. Liquid
6.3. Lyophilized

7. Antithrombin Market, by Source

7.1. Introduction
7.2. Goat Milk
7.3. Human

8. Antithrombin Market, by Type

8.1. Introduction
8.2. Anticoagulant
8.3. Antiplatelet
8.4. Thrombolytic Drugs

9. Antithrombin Market, by Route

9.1. Introduction
9.2. Oral
9.3. Parenteral

10. Antithrombin Market, by Application

10.1. Introduction
10.2. Diagnostics
10.3. Research
10.4. Therapeutics

11. Americas Antithrombin Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Antithrombin Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Antithrombin Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

15.1. Key Company Profiles
15.1.1. Bio-Techne Corporation
15.1.2. BioPharm Laboratories, LLC
15.1.3. CSL Limited
15.1.4. Diapharma Group, Inc.
15.1.5. European Medicines Agency
15.1.6. Genesis BioPharma
15.1.7. Grifols, S.A.
15.1.8. Kedrion S.p.A.
15.1.9. Lee Biosolutions, Inc.
15.1.10. LFB USA, Inc.
15.1.11. Merck KGaA
15.1.12. Octapharma AG
15.1.13. Scripps Laboratories, Inc.
15.1.14. Siemens AG
15.1.15. SK Plasma
15.1.16. Takeda Pharmaceutical Company Limited
15.1.17. Thermo Fisher Scientific Inc.
15.1.18. WebMD, LLC
15.2. Key Product Portfolio

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing

List of Figures

FIGURE 1. ANTITHROMBIN MARKET RESEARCH PROCESS
FIGURE 2. ANTITHROMBIN MARKET SIZE, 2023 VS 2030
FIGURE 3. ANTITHROMBIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ANTITHROMBIN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ANTITHROMBIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ANTITHROMBIN MARKET DYNAMICS
FIGURE 7. ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
FIGURE 8. ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ANTITHROMBIN MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 10. ANTITHROMBIN MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ANTITHROMBIN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 12. ANTITHROMBIN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. ANTITHROMBIN MARKET SIZE, BY ROUTE, 2023 VS 2030 (%)
FIGURE 14. ANTITHROMBIN MARKET SIZE, BY ROUTE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 16. ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ANTITHROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS ANTITHROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ANTITHROMBIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES ANTITHROMBIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANTITHROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANTITHROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANTITHROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANTITHROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. ANTITHROMBIN MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. ANTITHROMBIN MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. ANTITHROMBIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. ANTITHROMBIN MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANTITHROMBIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 6. ANTITHROMBIN MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ANTITHROMBIN MARKET SIZE, BY LYOPHILIZED, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 9. ANTITHROMBIN MARKET SIZE, BY GOAT MILK, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. ANTITHROMBIN MARKET SIZE, BY HUMAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 12. ANTITHROMBIN MARKET SIZE, BY ANTICOAGULANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. ANTITHROMBIN MARKET SIZE, BY ANTIPLATELET, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. ANTITHROMBIN MARKET SIZE, BY THROMBOLYTIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 16. ANTITHROMBIN MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. ANTITHROMBIN MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. ANTITHROMBIN MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. ANTITHROMBIN MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. ANTITHROMBIN MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS ANTITHROMBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. CANADA ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 39. CANADA ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 40. CANADA ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. CANADA ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 42. CANADA ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. MEXICO ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 44. MEXICO ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 45. MEXICO ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 47. MEXICO ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES ANTITHROMBIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC ANTITHROMBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. CHINA ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 66. CHINA ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 67. CHINA ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. CHINA ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 69. CHINA ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. INDIA ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 71. INDIA ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 72. INDIA ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. INDIA ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 74. INDIA ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. INDONESIA ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. JAPAN ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 81. JAPAN ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 82. JAPAN ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. JAPAN ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 84. JAPAN ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. MALAYSIA ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 86. MALAYSIA ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. PHILIPPINES ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 91. PHILIPPINES ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. SINGAPORE ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 96. SINGAPORE ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. SOUTH KOREA ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 101. SOUTH KOREA ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. TAIWAN ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 106. TAIWAN ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. THAILAND ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 111. THAILAND ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 112. THAILAND ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. THAILAND ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 114. THAILAND ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. VIETNAM ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 116. VIETNAM ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA ANTITHROMBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 126. DENMARK ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 127. DENMARK ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 128. DENMARK ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. DENMARK ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 130. DENMARK ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. EGYPT ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 132. EGYPT ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 133. EGYPT ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. EGYPT ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 135. EGYPT ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. FINLAND ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 137. FINLAND ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 138. FINLAND ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. FINLAND ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 140. FINLAND ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. FRANCE ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 142. FRANCE ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 143. FRANCE ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. FRANCE ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 145. FRANCE ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. GERMANY ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 147. GERMANY ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 148. GERMANY ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. GERMANY ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 150. GERMANY ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. ISRAEL ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. ITALY ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 157. ITALY ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 158. ITALY ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. ITALY ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 160. ITALY ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. NIGERIA ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 167. NIGERIA ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. NORWAY ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 172. NORWAY ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 173. NORWAY ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. NORWAY ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 175. NORWAY ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. POLAND ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 177. POLAND ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 178. POLAND ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 179. POLAND ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 180. POLAND ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. QATAR ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 182. QATAR ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 183. QATAR ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. QATAR ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 185. QATAR ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. SPAIN ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 202. SPAIN ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 203. SPAIN ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 204. SPAIN ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 205. SPAIN ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. SWITZERLAND ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 212. SWITZERLAND ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 213. SWITZERLAND ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. TURKEY ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 217. TURKEY ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 218. TURKEY ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 219. TURKEY ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 220. TURKEY ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. UNITED KINGDOM ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM ANTITHROMBIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM ANTITHROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM ANTITHROMBIN MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. ANTITHROMBIN MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 232. ANTITHROMBIN MARKET SHARE, BY KEY PLAYER, 2023
TABLE 233. ANTITHROMBIN MARKET LICENSE & PRICING

Companies Mentioned

Bio-Techne Corporation
BioPharm Laboratories, LLC
CSL Limited
Diapharma Group, Inc.
European Medicines Agency
Genesis BioPharma
Grifols, S.A.
Kedrion S.p.A.
Lee Biosolutions, Inc.
LFB USA, Inc.
Merck KGaA
Octapharma AG
Scripps Laboratories, Inc.
Siemens AG
SK Plasma
Takeda Pharmaceutical Company Limited
Thermo Fisher Scientific Inc.
WebMD, LLC

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	180
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 876.87 Million
Forecasted Market Value ( USD ) by 2030	$ 1575.32 Million
Compound Annual Growth Rate	10.2%
Regions Covered	Global
No. of Companies Mentioned	18

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,804GBP €3624EUR$3,749USD£3,115GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4132EUR$4,274USD£3,551GBP €4591EUR$4,749USD£3,946GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5002EUR$5,174USD£4,299GBP €5558EUR$5,749USD£4,777GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5872EUR$6,074USD£5,047GBP €6524EUR$6,749USD£5,608GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7612EUR$7,874USD£6,543GBP €8458EUR$8,749USD£7,270GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Antithrombin: Global Strategic Business Report

Global Antithrombin Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Antithrombin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

Global Hemostasis Market Database for the US, Europe, Japan - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 40 Coagulation Tests

United Arab Emirates Hemostasis Market Database - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 40 Coagulation Tests

About the Antithrombin Test Market